Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

NCT01711840 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2409

Last updated 2016-07-18

No results posted yet for this study

Summary

The purpose of the investigation is to confirm the safety of patients receiving Symbicort Turbuhaler as maintenance and reliever therapy ( Symbicort SMART) under the post-marketing actual use.

Conditions

  • Bronchial Asthma

Sponsors & Collaborators

Principal Investigators

  • Shigeru Yoshida, MD · AstraZeneca KK

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01711840 on ClinicalTrials.gov